CJC-1295 (No DAC) + Ipamorelin

CJC-1295 (No DAC), also known as Modified GRF (1-29), is a 29-amino-acid synthetic analogue of growth hormone-releasing hormone (GHRH) studied in growth hormone synthesis research. Unlike the DAC (Drug Affinity Complex) version, this No-DAC variant does not bind serum albumin, so it has a short circulating half-life and produces a more pulsatile GH-release profile in research models. CJC-1295 binds the GHRH receptor on pituitary somatotrophs, activating the Gs/cAMP/PKA signalling cascade to stimulate growth hormone gene transcription. It is frequently studied alongside GHSR agonists such as Ipamorelin to explore complementary pathways of the GH axis. AllMyPeptides supplies CJC-1295 (No DAC) in lyophilised vials, with every batch independently HPLC-tested by UK-based third-party laboratories to 99%+ purity, and a batch-matched Certificate of Analysis included with every order.